Eli Lilly has already sued four telehealth companies, including Fella Health and Henry Meds, for allegedly selling knockoff tirzepatide without evidence of safety or effectiveness after the FDA ruled that they had to stop
Research Interest in BPC-157 + TB-500 Capsules BPC-157 + TB-500 capsules are part of a broader research peptide category that includes vials, sprays, capsules, and blended peptide formulations
Here, four people share their experiences of weight-loss jabs
The study was conducted in accordance with the Declaration of Helsinki
It is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for tolerability and gradually titrated upward based on individual response
KLOW combines four structurally and mechanistically distinct peptides